ANI Pharmaceuticals is a diversified biopharmaceutical company that develops, manufactures, and commercializes therapeutics across rare disease, generic, and branded segments. Its portfolio includes Cortrophin Gel for chronic autoimmune disorders, a retina franchise focused on eye diseases, and over 120 generic products addressing diverse indications. The company operates manufacturing facilities and generates revenue through national wholesalers, specialty pharmacies, retail pharmacy chains, and direct contracts with hospitals and healthcare providers, with significant concentration among major customers reflecting industry consolidation.